Showing results (31-40 of 67) with videos related to
Sort By:
Pageof 7
Chest|March 3, 2024
Clinical Correlates of a Nonplexiform Vasculopathy in Patients With a Diagnosis of Idiopathic Pulmonary Arterial HypertensionEsther J Nossent, Josien A Smits, Celine Seegers, et al.Pulmonary Circulation|January 26, 2024
Patients with CTEPH and mild hemodynamic severity of disease improve to a similar level of exercise capacity after pulmonary endarterectomy compared to patients with severe hemodynamic diseaseCoen van Kan, Jelco Tramper, Paul Bresser, et al.The European Respiratory Journal|July 27, 2022
Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patientsJustin de Brabander, Erik Duijvelaar, Job R Schippers, et al.Circulation|October 27, 2012
Effective treatment of edema and endothelial barrier dysfunction with imatinibJurjan Aman, Jan van Bezu, Amin Damanafshan, et al.Pulmonary Circulation|July 19, 2021
Application of [18F]FLT-PET in pulmonary arterial hypertension: a clinical study in pulmonary arterial hypertension patients and unaffected bone morphogenetic protein receptor type 2 mutation carriersLiza Botros, Samara M A Jansen, Ali Ashek, et al.Pulmonary Circulation|July 22, 2024
Integrated approach of network pharmacology, molecular docking, and clinical observations in evaluating the efficacy and safety of Bufei Huoxue capsules for pulmonary hypertension associated with chronic obstructive pulmonary diseaseWenjun He, Chunli Liu, Xuanyi Li, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|May 29, 2024
Pneumonectomy combined with SU5416 or monocrotaline pyrrole does not cause severe pulmonary hypertension in miceXiao-Qing Sun, Timothy Klouda, Suzanne Barnasconi, et al.CPT: Pharmacometrics & Systems Pharmacology|February 22, 2025
Disease-Drug-Drug Interaction of Imatinib in COVID-19 ARDS: A Pooled Population Pharmacokinetic AnalysisMedhat M Said, Job R Schippers, Leila Atmowihardjo, et al.European Journal of Immunology|March 26, 2021
Enrichment of CCR6+ CD8+ T cells and CCL20 in the lungs of mechanically ventilated patients with COVID-19Anno Saris, Tom D Y Reijnders, Martine Reijm, et al.Journal of the American Heart Association|July 25, 2026
Empagliflozin Ameliorates Experimental Pulmonary Vascular Remodeling, but May Not Benefit Patients With Pulmonary Arterial HypertensionKeimei Yoshida, Eszter Toth, Erik Duijvelaar, et al.Pageof 7